Genenta Science S.p.A. American Depositary Shares

GNTA XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

77M

Short interest (Jul 15)

0.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

68.92%

↓ 37.6%

Available Shares

200K

↓ 32.2%

Price Chart

Company Overview

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Company Info

Exchange: NASDAQ

CIK: 0001838716

Asset Type: ADRC

Market Data

Market Cap: $76,664,804

Employees: 9

Status: Active

Short Interest

Current Borrow Fee 68.92%

Range: 68.92% - 68.92%

Available Shares 200K

Range: 100K - 150K

Recent Changes

Fee Change: ↓ 13.4%

Available Change: ↓ 16.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime